Skip to main content

Table 1 Patient clinical characteristics

From: Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT

Patient (No)

Age (y)

Gender

Primary tumor

Biopsy site

Tumor grade

Ki67 value

Indication of imagine

Primary tumor resected

Time between scans

(days)

1

55

M

Throat

Throat

1

2

Restage

Yes

147

2

52

M

Ileocecus

Ileocecus

2

NA

Restage

Yes

2

3

63

M

Rectum

Rectum

2

3

Restage

Yes

5

4

42

F

Rectum

Rectum

1

1

Stage

No

2

5

24

F

Pancreas

Liver

3

40

Restage

No

4

6

65

M

Stomach

Stomach

3

70

Stage

No

4

7

57

M

Pancreas

Pancreas

1

1

Stage

No

2

8

29

F

Unknown

liver

2

8

Stage

No

1

9

48

F

Rectum

Rectum

2

NA

Restage

Yes

5

10

70

F

Small intestine

Small intestine

1

NA

Restage

Yes

8

11

67

M

Pancreas

Liver

2

NA

Stage

No

7

12

68

M

Pancreas

Liver

1

 < 2

Stage

No

5

13

59

M

Unknown

Liver

1

1

Stage

No

1

14

60

F

Pancreas

Pancreas

1

1

Stage

No

1

15

46

F

Unknown

Liver and Celiac

1

1

Stage

No

279

16

56

F

Pancreas

Pancreas

Insulinoma

Stage

No

1

17

57

M

Unknown

Neck

2

15

Stage

No

1

18

50

M

Pancreas

Pancreas

2

10

Stage

No

1

19

49

M

Rectum

Rectum

2

5

Restage

Yes

2

20

47

F

Paraganglioma

Retroperitoneum

NA

NA

Stage

No

1

  1. NA not applicable